Abstract
The Effect of Crizanlizumab on the Number of Days Requiring Opioid Use for Management of Pain Associated with Vaso-Occlusive Crises in Patients with Sickle Cell Disease: Results from the Sustain Trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have